631 related articles for article (PubMed ID: 32196665)
1. Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
Klein P; Friedman A; Hameed MQ; Kaminski RM; Bar-Klein G; Klitgaard H; Koepp M; Jozwiak S; Prince DA; Rotenberg A; Twyman R; Vezzani A; Wong M; Löscher W
Epilepsia; 2020 Mar; 61(3):359-386. PubMed ID: 32196665
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology for antiepileptogenesis: Tolerability and neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status epilepticus mice.
Welzel L; Twele F; Schidlitzki A; Töllner K; Klein P; Löscher W
Epilepsy Res; 2019 Mar; 151():48-66. PubMed ID: 30831337
[TBL] [Abstract][Full Text] [Related]
3. The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments.
Löscher W
Neuropharmacology; 2020 May; 167():107605. PubMed ID: 30980836
[TBL] [Abstract][Full Text] [Related]
4. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.
Löscher W; Brandt C
Pharmacol Rev; 2010 Dec; 62(4):668-700. PubMed ID: 21079040
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Effects of Time-Limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat.
Eastman CL; Fender JS; Klein P; D'Ambrosio R
J Pharmacol Exp Ther; 2021 Dec; 379(3):310-323. PubMed ID: 34593559
[TBL] [Abstract][Full Text] [Related]
6. Combination Therapy of Gabapentin and N-Acetylcysteine Against Posttraumatic Epilepsy in Rats.
Efendioglu M; Basaran R; Akca M; Ceman D; Demirtas C; Yildirim M
Neurochem Res; 2020 Aug; 45(8):1802-1812. PubMed ID: 32372158
[TBL] [Abstract][Full Text] [Related]
7. Commonalities in epileptogenic processes from different acute brain insults: Do they translate?
Klein P; Dingledine R; Aronica E; Bernard C; Blümcke I; Boison D; Brodie MJ; Brooks-Kayal AR; Engel J; Forcelli PA; Hirsch LJ; Kaminski RM; Klitgaard H; Kobow K; Lowenstein DH; Pearl PL; Pitkänen A; Puhakka N; Rogawski MA; Schmidt D; Sillanpää M; Sloviter RS; Steinhäuser C; Vezzani A; Walker MC; Löscher W
Epilepsia; 2018 Jan; 59(1):37-66. PubMed ID: 29247482
[TBL] [Abstract][Full Text] [Related]
8. Antiepileptogenesis in humans: disappointing clinical evidence and ways to move forward.
Trinka E; Brigo F
Curr Opin Neurol; 2014 Apr; 27(2):227-35. PubMed ID: 24556736
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptogenesis and disease modification: Clinical and regulatory issues.
French JA; Bebin M; Dichter MA; Engel J; Hartman AL; Jóźwiak S; Klein P; McNamara J; Twyman R; Vespa P
Epilepsia Open; 2021 Sep; 6(3):483-492. PubMed ID: 34270884
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology for antiepileptogenesis: Tolerability of multitargeted drug combinations in nonepileptic vs. post-status epilepticus mice.
Klee R; Töllner K; Rankovic V; Römermann K; Schidlitzki A; Bankstahl M; Löscher W
Epilepsy Res; 2015 Dec; 118():34-48. PubMed ID: 26600369
[TBL] [Abstract][Full Text] [Related]
11. In search of antiepileptogenic treatments for post-traumatic epilepsy.
Saletti PG; Ali I; Casillas-Espinosa PM; Semple BD; Lisgaras CP; Moshé SL; Galanopoulou AS
Neurobiol Dis; 2019 Mar; 123():86-99. PubMed ID: 29936231
[TBL] [Abstract][Full Text] [Related]
12. Brivaracetam prevents the development of epileptiform activity when administered early after cortical neurotrauma in rats.
Ling DSF; Yang L; Goodman JH
Epilepsia; 2022 Apr; 63(4):992-1002. PubMed ID: 35037242
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies.
Łukawski K; Andres-Mach M; Czuczwar M; Łuszczki JJ; Kruszyński K; Czuczwar SJ
Pharmacol Rep; 2018 Apr; 70(2):284-293. PubMed ID: 29477036
[TBL] [Abstract][Full Text] [Related]
14. 4-AP challenge reveals that early intervention with brivaracetam prevents posttraumatic epileptogenesis in rats.
Mejia-Bautista A; Michelson HB; Sanjana A; Famuyiwa O; Goodman JH; Ling DSF
Epilepsy Res; 2023 Oct; 196():107217. PubMed ID: 37619297
[TBL] [Abstract][Full Text] [Related]
15. Pregabalin add-on for drug-resistant focal epilepsy.
Panebianco M; Bresnahan R; Hemming K; Marson AG
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
[TBL] [Abstract][Full Text] [Related]
16. Systematic evaluation of rationally chosen multitargeted drug combinations: a combination of low doses of levetiracetam, atorvastatin and ceftriaxone exerts antiepileptogenic effects in a mouse model of acquired epilepsy.
Welzel L; Bergin DH; Schidlitzki A; Twele F; Johne M; Klein P; Löscher W
Neurobiol Dis; 2021 Feb; 149():105227. PubMed ID: 33347976
[TBL] [Abstract][Full Text] [Related]
17. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.
Kaminski RM; Rogawski MA; Klitgaard H
Neurotherapeutics; 2014 Apr; 11(2):385-400. PubMed ID: 24671870
[TBL] [Abstract][Full Text] [Related]
18. Epileptogenesis, traumatic brain injury, and biomarkers.
Engel J
Neurobiol Dis; 2019 Mar; 123():3-7. PubMed ID: 29625256
[TBL] [Abstract][Full Text] [Related]
19. Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force.
Tomson T; Battino D; Bromley R; Kochen S; Meador KJ; Pennell PB; Thomas SV
Epileptic Disord; 2022 Dec; 24(6):1020-1032. PubMed ID: 36193017
[TBL] [Abstract][Full Text] [Related]
20. Anti-epileptogenesis in rodent post-traumatic epilepsy models.
Pitkänen A; Bolkvadze T; Immonen R
Neurosci Lett; 2011 Jun; 497(3):163-71. PubMed ID: 21402123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
